Navigation Links
IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference
Date:4/11/2008

Uniting venture capitalists, investment bankers, international start-up CEOs, business development executives, and service providers from across

the globe

MASSAPEQUA, N.Y. and CLEVELAND, April 11 /PRNewswire/ -- IBF Conferences, Inc., the leading national investment conference organizer, and BioEnterprise Corporation, the Cleveland-based bioscience business formation, recruitment, and acceleration initiative, are proud to present the 2nd annual Global Healthcare Investing Conference. The conference brings together the leading- edge investors, institutions, providers and companies that invest in healthcare technologies across the world, manage "global" start-ups, and operate in multiple financial and regulatory markets.

The forum is geared specifically to US and international investors in and entrepreneurs of emerging bioscience companies. The event will be held April 29 -- May 1, 2008 in Cleveland, Ohio, and is expected to once again draw over 70+ investment firms and 300+ attendees.

This year, company presentations will be at the forefront of the conference. Each presenting company is ex-US or cross-border, and has received at least one round of professional funding. These companies span the life science industry, including medical devices, diagnostics, drug delivery, drug discovery, biotechnology and healthcare information technologies. This year's selected presenting companies include the following:

Country Company Sector

Shanghai, China GammaStar Medical Devices

Group Ltd.

Hoersholm, Denmark Santaris BioPharmaceutical

Pharmaceutical

California, USA Napo Pharmaceutical BioPharmaceutical

Wurmlingen, Paradigm Spine, LLC Devices

Germany

Tokyo, Japan EyePlusPlus, Inc. Devices

Peronnas -- France Small Bone Innovations Devices

Galway, Ireland Proxy Biomedical Devices

Limited

London, England CYTOX Limited Diagnostics

Tokyo, Japan Glycosience Biopharmaceuticals

Laboratories

Goias, Brazil Scitech Produtos Devices

Medicos Ltda.

Tennessee, USA Asklepion Biopharmaceuticals

Pharmaceuticals

Allschwill, Evolva SA Biopharmaceuticals

Switzerland

Belo Horizonte, Alvos Biotec Biopharmaceuticals

Brazil

Yokneam, Israel Navotek Medical Ltd. Devices

Ohio, USA m2m Imaging Corp. Devices

You may view company abstracts by visiting http://www.globalhealthcareinvesting.com

This year's conference sponsors have raised the bar on helping secure speakers and presenting companies. 2008's sponsors include: Squire Sanders & Dempsey, LLP; Musculoskeletal Clinical Regulatory Advisers, LLC; UK Trade & Investment; and National City. To learn more about the event and to register, please visit http://www.globalhealthcareinvesting.com.

About BioEnterprise

BioEnterprise is a business formation, recruitment, and acceleration effort designed to support the growth of bioscience companies. Located in Cleveland, BioEnterprise provides management counsel and support services to health care companies. BioEnterprise's partners are Case Western Reserve University, the Cleveland Clinic, University Hospitals, and Summa Health System. Additional technology partners include the NASA Glenn Research Center, Cleveland State University, NorTech and BioOhio.

The initiative comprises the collaborative activities of BioEnterprise and its partners' commercialization offices: the Case Office of Technology Transfer, Cleveland Clinic Innovations, University Hospitals Case Medical Center -- Center for Clinical Research, and Summa Enterprise Group. The combined efforts of these groups has created, recruited, and accelerated more than 60 companies in four years.

About IBF Conferences

IBF -- International Business Forum presents financial and business conferences on venture capital, corporate finance, mergers & acquisitions, corporate strategic investing, investment management, risk management, funding technology innovation, commercialization of intellectual property and corporate employee benefits. IBF conferences provide attendees with leading-edge information, and new business contacts to achieve business objectives.

Founded in 1989 by Alexandra Scott, International Business Forum organizes conferences to provide strategic information and key business contacts. Attendees include: venture capitalists, investment and commercial bankers, chief executive officers, chief financial officers, pension, endowment and foundation investment officers, corporate investors, money managers, new business development executives and corporate decision makers.


'/>"/>
SOURCE IBF Conferences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences
2. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
3. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
4. Oncothyreon to present at upcoming investment conferences
5. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
6. BD to Present at Investor Healthcare Conferences
7. IBF Conferences Inc., (International Business Forum) and BioEnterprise Present the 2nd Annual Global Healthcare Investing Conference
8. Micromet to Present at Two Upcoming Investor Conferences
9. SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Monsanto Executives to Address Investor Conferences in February
11. NicOx to Present at Financial Conferences in New York on November 27, 28 and 29
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... SAN JOSE, Calif. , Feb. 23, 2017 ... an exclusive license for two key immunotherapy technologies ... The first technology provides a method to monitor ... therapy such as PD-L1 and CTLA-4.  The second ... detect if a patient is likely to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... in a published evaluation of multiple immunoassay-based threat detection technologies by researchers ... Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have the ...
(Date:2/23/2017)... 23, 2017 Aviva Systems Biology Corporation ... acquisition of GenWay Biotech Incorporated, a protein solutions ... product offering for both the research and diagnostic ... and enhance capabilities for both entities. GenWay,s 18 years ... will nicely complement ASB,s objective to become a ...
Breaking Biology Technology:
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):